Rosiglitazone attenuates amyloid beta and glial fibrillary acidic protein in the hippocampus and neuroinflammation associated learning and memory impairments in rats

The aim of the current study was to investigate the beneficial effects of rosiglitazone (Rosi) on amyloid beta(Aβ) and glial fibrillary acidic protein (GFAP) in the hippocampus and neuroinflammation-associated learning and memory impairments in rats. The rats were grouped and treated as follows: (1)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Behavioural brain research 2023-08, Vol.452, p.114549-114549, Article 114549
Hauptverfasser:	Beheshti, Farimah, Hosseini, Mahmoud, Bakhtiari-Dovvombaygi, Hossein, Salmani, Hossein, Ahmadabady, Somaieh, Marefati, Narges, Baghcheghi, Yousef
Format:	Artikel
Sprache:	eng
Schlagworte:	Amyloid beta Amyloid beta-Peptides - metabolism Animals Cytokines Glial fibrillary acidic protein Glial Fibrillary Acidic Protein - metabolism Hippocampus - metabolism Interleukin-6 - metabolism Learning Lipopolysaccharides - metabolism Lipopolysaccharides - pharmacology Maze Learning Memory Memory Disorders - drug therapy Memory Disorders - metabolism Neuroinflammation Neuroinflammatory Diseases Oxidative Stress Rats Rats, Wistar Rosiglitazone Rosiglitazone - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!